Ablation company takes on a new tech, and responsibility for an expensive clinical trial.
Alcohol kills – and in this case, that could be a good thing.
Vascular robotics is growing fast and Corindus is the leader here, but Healthineers will need an aggressive sales plan.
Medtronic decides that Solitaire is best played with a partner.
The deal is 2019’s second-biggest medtech flotation, and the fourth-biggest ever.
With little cash in the bank and creditors soon to start pressing, a trial failure is a disaster for Viveve.
The overall rate of device approvals in 2019 is holding steady on last year – but the types of approvals are different.
Most medtechs that listed this year priced their IPOs at a premium, and most saw their shares appreciate.
The first one-shot billion-dollar venture investment round in the medical technology sector has gone to Verily as computing bleeds into medicine.